Search Results - "Boucot, I"

The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review by Roche, N., Aggarwal, B., Boucot, I., Mittal, L., Martin, A., Chrystyn, H.

“…Many patients with asthma use their inhalers incorrectly, which can lead to sub-optimal asthma control and an increased risk of exacerbations. The…”
Get full text

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial by Maltais, F, Naya, I P, Vogelmeier, C F, Boucot, I H, Jones, P W, Bjermer, L, Tombs, L, Compton, C, Lipson, D A, Kerwin, E M

“…Short-acting β -agonist (SABA) bronchodilators help alleviate symptoms in chronic obstructive pulmonary disease (COPD) and may be a useful marker of symptom…”
Get full text

Patterns of systemic lupus erythematosus expression in Europe by Cervera, R, Doria, A, Amoura, Z, Khamashta, M, Schneider, M, Guillemin, F, Maurel, F, Garofano, A, Roset, M, Perna, A, Murray, M, Schmitt, C, Boucot, I

“…Abstract Objectives To analyse the differences in disease expression of European SLE patients based on gender, age at diagnosis, and ethnicity. Methods A…”
Get full text

Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model by Shukla, Soham, Shah, Dhvani, Martin, Alan, Risebrough, Nancy A, Kendall, Robyn, Vogelmeier, Claus F, Boucot, Isabelle, Tombs, Lee, Bjermer, Leif, Jones, Paul W, Kerwin, Edward, Compton, Chris, Maltais, François, Lipson, David A, Ismaila, Afisi S

“…Dual bronchodilators are recommended as maintenance treatment for patients with symptomatic COPD in the UK; further evidence is needed to evaluate…”
Get full text

A Bayesian Dynamic Model of Asthma in the Real Life by Amzal, B, Timmaraju, V, Castelnuovo, E, Boucot, I, Pribil, C, Nachbaur, G

Get full text

Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement by Vogelmeier, Claus F, Naya, Ian P, Maltais, François, Bjermer, Leif, Kerwin, Edward M, Tombs, Lee, Jones, Paul W, Compton, Chris, Lipson, David A, Boucot, Isabelle H

“…This post hoc analysis of the "Early MAXimization of bronchodilation for improving COPD stability" (EMAX) trial investigated whether patients achieving early…”
Get full text

Phenotype of asthmatic patients according to a score derived from the Asthma Control Test by Godard, P, Boucot, I, Pribil, C, Huas, D

“…Today the control of asthma is a key element of national and international guidelines. The ER'Asthma survey, created in 2003, measured the control of asthma…”
Get more information

Asthma control level in asthmatic children followed in general practice medicine in France: results of ER'ASTHME study by de Blic, J, Boucot, I, Pribil, C, Huas, D, Godard, P

“…Little information is available on asthma control level in children in France in general practice medicine although such control is 1 of the essential goals of…”
Get full text

The burden of COPD in France: results from the confronting COPD survey by Piperno, D., Huchon, G., Pribil, C., Boucot, I., Similowski, T.

“…Chronic obstructive pulmonary disease (COPD) is an obstructive lung disorder characterized by progressive airflow limitation that is not reversible or only…”
Get full text

PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study): French Results by Amoura, Z, Pennaforte, J.L, Hamidou, M, Arfi, S, Lazaro, E, Hachulla, E, Pourrat, J, Queyrel, V, Aubin, C, Garofano, A, Levy-Bachelot, L, Maurel, F, Boucot, I

Get full text

PSY17 Retrospective Chart Review Study of the Cost of Care of Systemtic Lupus Erythematousus (Sle) in Five European Countries by Doria, A, Amoura, Z, Richter, J, Cervera, R, Khamashta, M, Guillemin, F, Garofanno, A, Maurel, F, Roset, M, Perna, A, Schmitt, C, Ager, M, Boucot, I, McQuire, S. Gonzalez, Birch, H

Get full text

Coût du lupus systémique en France des patients adultes avec une maladie active et traitée (étude LUCIE) by Amoura, Z., Deligny, C., Pennaforte, J.-L., Hamidou, M., Blanco, P., Hachulla, E., Pourrat, J., Queyrel, V., Garofano, A., Maurel, F., Levy-Bachelot, L., Boucot, I.

“…Évaluer en France le coût médical direct annuel des patients lupiques adultes, traités, actifs avec auto-anticorps positifs, et estimer le coût d’une poussée…”
Get full text

Clonal distribution of penicillin-resistant Streptococcus pneumoniae 23F in France by FERRONI, A, NGUYEN, L, GEHANNO, P, BOUCOT, I, BERCHE, P

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Lung cancer in the elderly subject by Albrand, G, Biron, E, Boucot, I, Couderc, L J, Crestani, B, Dombret, M C, Guenard, H, Grivaux, M, Hervy, M P, Housset, B, Jougon, J, Orvoen-Frija, E, Piette, F, Pignon, T, Pinganaud, G, Puisieux, F, Quoix, E, Sauty, E, Vaylet, F, Wary, B, Weill-Engerer, S, Westeel, V, Wislez, M

“…In France, the average age for the diagnosis of bronchial carcinoma is 64. It is 76 in the population of over 70. In fact, its incidence increases with age…”
Get more information

PRS10 Economic Evaluation of Umeclidinium/Vilanterol Versus Umeclidinium or Salmeterol in a UK COPD Population at Low Risk of Exacerbations Using the GALAXY Model by Shukla, S., Shah, D., Martin, A., Risebrough, N.A., Kendall, R., Vogelmeier, C.F., Boucot, I., Tombs, L., Bjermer, L., Jones, P., Kerwin, E., Compton, C., Maltais, F., Lipson, D., Ismaila, A.

Get full text

Coryneform bacteria isolated from middle ear fluid by SIMONET, M, DE BRIEL, D, BOUCOT, I, MINCK, R, VERON, M

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: The Clinical Effectiveness Of Fluticasone Furoate/vilanterol (ff/vi) In Everyday Clinical Practice: Patient Reported Outcomes In The Salford Lung Study (sls COPD) by Woodcock, A A, Boucot, I, Browning, D, Collier, S, Sedgley, J, Millar, J, Lay-Flurrie, J, McCorkindale, S, Vestbo, J

“…Corresponding author's email: ashley.woodcock@manchester.ac.uk Rationale: SLS COPD was a 12-month, open-label, randomized, controlled trial comparing…”
Get full text

A48 COPD: ISSUES IN HEALTH CARE DELIVERY: Health Care Resource Utilisation Data From Sls COPD by Vestbo, J, Elkhenini, H, Browning, D, Boucot, I, Flemming, J, Boladz, R, Crawford, J, McCorkindale, S, New, J P

“…Rationale: SLS COPD evaluated the effectiveness and safety of once-daily inhaled FF/VI versus existing maintenance therapy (usual care; UC) in patients with a…”
Get full text

Niveau de contrôle de l'asthme chez l'enfant en médecine générale en France : résultats de l'étude ER'ASTHME by de Blic, J., Boucot, I., Pribil, C., Huas, D., Godard, P.

“…Dans l'asthme, la notion de contrôle occupe aujourd'hui une place centrale dans les recommandations nationales et internationales. Elle permet d'envisager le…”
Get full text

Patient perspective on zanamivir in the treatment of influenza by Bricaire, F, Cohen, J M, Jacquet, M, Boucot, I, Nicolas, M

“…Placebo-controlled clinical studies have shown zanamivir to be an effective treatment of influenza A and influenza B illness. This survey, conducted in France,…”
Get more information